MUSE Microscopy, Inc. is Entering a New Era of Digital Pathology with the Development of the SmartPath MUSE Technology (SmartPath) Imager
MUSE Microscopy, Inc., a innovator in digital pathology announced it’s in their final phase. After a strategic acquisition by the current leadership team in 2021, MUSE has steadfastly pursued a visionary roadmap that has the potential to reshape the future of digital pathology. Today, that journey reaches an exciting moment with SmartPath MUSE Technology™ (SmartPath)—the […]
Pivotal Developmental Milestone Unveiled by MUSE Microscopy, Inc. at CAP24 Pathology Conference
Pivotal Developmental Milestone Unveiled by MUSE Microscopy, Inc. at CAP24 Pathology Conference MUSE Microscopy, Inc., has reached a pivotal developmental milestone, unveiling a preliminary version of its innovative SmartPath Imager at the recent CAP24 Pathology Conference in Las Vegas, NV. We introduced SmartPath as the first tissue-to-digital™ imager utilizing MUSE (Microscopy with Ultraviolet Surface Excitation) […]
Muse Microscopy, Inc. to Present SmartPath MUSE Technology™ (SmartPath) at Upcoming Emerging Medtech Summit (LSI USA ’24) in Dana Point, CA
IRVINE, Calif., March 6, 2024 /PRNewswire/ — Muse Microscopy, Inc., a wholly-owned subsidiary of Smart Health Diagnostics Company, is developing a slide-free diagnostic imaging platform designed to transform the patient’s experience by providing the ability to generate digital tissue images within minutes to send to the pathologist for an immediate read. Larry Dentice, the President and Director […]
SmartPath Dx is Changing Pathology Image by Image, Minute by Minute – SmartHealth Dx announces the unveiling of SmartPath Dx at Octane’s Medical Innovation Forum
IRVINE, Calif., October 25, 2023 /PRNewswire/ — Smart Health Diagnostics Company (“SHDx” or “the Company”), a developer of precision diagnostic tests and imaging technologies that address unmet clinical needs for advancing today’s standards of care, today announced its upcoming participation in Octane’s Medical Innovation Forum 2023 to discuss SmartPath Dx’s impact on human health in the pathology […]
SmartHealth Dx Featured in Cover Story of Med Tech Outlook Magazine’s Pathology Special Edition
IRVINE, Calif., June 13, 2023 /PRNewswire/ — Smart Health Diagnostics Company (“SHDx” or “the Company”), a developer of precision diagnostic tests that address unmet clinical needs in pathology and vascular inflammation for advancing today’s standards of care, announced that CEO and Chairman Mitch Levine is featured in the June 8, 2023 edition of Med Tech […]
SmartHealth Diagnostics Appoints Accomplished Corporate and Finance Leader Mitch Levine as President, Chief Financial Officer, and Director
Highly regarded diagnostics industry executive and capital markets expert to guide planned growth and value creation for evolutionary data-to-diagnostics platform company